Celsius HoldingsCELH
About: Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
Employees: 1,073
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
200% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 3 (+2) [Q4]
16% more call options, than puts
Call options by funds: $772M | Put options by funds: $664M
7% less repeat investments, than reductions
Existing positions increased: 147 | Existing positions reduced: 158
5.93% less ownership
Funds ownership: 68.26% [Q3] → 62.33% (-5.93%) [Q4]
12% less funds holding
Funds holding: 506 [Q3] → 445 (-61) [Q4]
22% less capital invested
Capital invested by funds: $4.99B [Q3] → $3.88B (-$1.11B) [Q4]
35% less first-time investments, than exits
New positions opened: 89 | Existing positions closed: 137
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Ladenburg Thalmann Jeffrey Cohen 50% 1-year accuracy 1 / 2 met price target | 68%upside $58 | Neutral Maintained | 27 Mar 2025 |
Needham Gerald Pascarelli 26% 1-year accuracy 6 / 23 met price target | 16%upside $40 | Buy Maintained | 25 Feb 2025 |
Roth MKM Sean McGowan 43% 1-year accuracy 12 / 28 met price target | 10%upside $38 | Buy Reiterated | 21 Feb 2025 |
B. Riley Securities Jeff Van Sinderen 39% 1-year accuracy 7 / 18 met price target | 42%upside $49 | Buy Reiterated | 21 Feb 2025 |
Stifel Mark Astrachan 43% 1-year accuracy 13 / 30 met price target | 7%upside $37 | Buy Maintained | 10 Feb 2025 |
Financial journalist opinion
Based on 33 articles about CELH published over the past 30 days









